The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
Adderall having a somewhat intermediate time course of action between ritalin which is short-lived and Vyvanse which is very long-lived perhaps is going to be the best solution for somebody else where they can take it early in the day perhaps at a low dose maybe again later in the day low dose and then still fall asleep at night
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.